Skip to main content

Table 2 Clinical pathological characteristics of the case series

From: Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence

  Total n (%) Disease recurrence n (%) No. of disease recurrence n (%) P
Gender     
 Male 56 (71.8) 24 (77.4) 32 (68.1)  
 Female 22 (28.2) 7 (22.6) 15 (31.9) 0.523
Median age, years (range)     
 Male 61 (42–85) 64 (48–85) 61 (42–79) 0.263
 Female 66 (40–81) 63 (51–72) 66 (40–81) 0.972
Risk of recurrence     
 High risk 43 (55.1) 16 (51.6) 27 (57.4)  
 Low risk 35 (44.9) 15 (48.4) 20 (42.6) 0.784
Dysplasia     
 Low (low and medium) grade 61 (78.2) 26 (83.9) 35 (74.5)  
 High grade 17 (21.8) 5 (16.1) 12 (25.5) 0.481
Lesion dimension     
 0–0.9 cm 9 (11.5) 3 (9.7) 6 (12.8)  
 ≥ 1 cm 29 (37.2) 11 (35.5) 18 (38.3)  
 Not specified 40 (51.3) 17 (54.8) 23 (48.9) 1.000
Lesion localization     
 Ascending colon 19 (24.4) 10 (32.3) 9 (19.1)  
 Descending colon 37 (47.4) 9 (29.0) 28 (59.6)  
 Mixed 22 (28.2) 12 (38.7) 10 (21.3) 0.015
Adenoma morphology     
 Tubular 46 (59.0) 19 (61.3) 27 (57.4)  
 Villous 3 (3.8) 0 3 (6.4)  
 Tubulovillous (mixed) 29 (37.2) 12 (38.7) 17 (36.2) 0.441